Ignite Creation Date:
2024-05-06 @ 9:45 AM
Last Modification Date:
2024-10-26 @ 12:19 PM
Study NCT ID:
NCT03064893
Status:
COMPLETED
Last Update Posted:
2020-03-24
First Post:
2016-12-14
Brief Title:
The Use of Alloderm Versus Dermacell in Immediate Implant Based Breast Reconstruction
Sponsor:
Ottawa Hospital Research Institute
Organization:
Ottawa Hospital Research Institute
Study Overview
Official Title:
A Randomised Controlled Trial Comparing the Use of Alloderm Versus Dermacell in Immediate Implant Based Breast Reconstruction
Status:
COMPLETED
Status Verified Date:
2020-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REaCT-ADM
Brief Summary:
Breast reconstruction after mastectomy has been shown to provide psychosocial benefits to breast cancer patients and is considered an integral part of breast cancer treatment In general breast reconstruction can be accomplished using the patients own tissues or implantable prosthetic devices Various acellular dermal matrices ADMs are offered on the market and the costs vary widely despite very similar qualities The two most commonly used ADM products in North America by far are Dermacell and Alloderm The difference between the two products include a level of sterility with Dermacell being sterilized to 10-9 while Alloderm is sterilized to 10-6 and b the consistency and thickness of the biologic material and c a significant different in cost 2200 CAD vs 3600 respectively Each product has shown to be safe and effective As such clinical equipoise exists This will be a pragmatic trial to evaluate Dermacell with Alloderm in a head to head randomized fashion with regards to the postoperative complications namely infection seroma formation as measured by drain duration and output loss of implant incidence of revisional surgery and capsular contracture
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None